President and Chief Executive Officer
Richard Ganz is a life sciences executive with over thirty years of experience in multinational pharma/device companies and venture-backed startups. He spent the first twenty years of his career at Abbott Laboratories, holding various positions in Sales, Marketing and General Management. His last position was Vice President and General Manager, Vascular Medicine. He joined Baxter Healthcare in 2001 as President, Renal North America. In 2004 he moved to Boston to join OmniSonics Medical Technologies as President and CEO. From 2012 to 2014 he was the Chief Operating Officer of Piramal Critical Care, a global leader in anesthetics. He founded RGA LifeSciences, a healthcare advisory company in 2014; assisting companies with formation, strategic planning and fundraising. From November, 2017 to February, 2020, He worked for Kairos Ventures as an Executive in Residence. He led two of the portfolio companies: Applaud Medical, Inc. and Domicell, Inc.
He joined Cambium Oncology in July of 2020 as President and Chief Executive Officer.
He has served on several private and one public company board of directors. Currently, he is executive chairman of Sentien Biotechnologies, a Boston based life sciences company, and serves on the board of Kalocyte, Inc. a Baltimore based life sciences company.
He has also been an executive in residence at the Cleveland Clinic and the University of Chicago.
Mr. Ganz received his M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University and a Bachelor of Arts from the University of Minnesota.